← Browse by Condition
Medical Condition
myelofibrosis mf
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT07128381 Phase 1, Phase 2
Recruiting
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
Enrollment
66 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06887803 Phase 1, Phase 2
Recruiting
A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors
Enrollment
26 pts
Location
Italy, Spain
Sponsor
iOnctura